Contrast developer Guerbet plans to showcase Vectorio, a new contrast media kit for diagnostic and interventional imaging, at the upcoming Cardiovascular and Interventional Radiological Society of Europe (CIRSE) congress in Lisbon.
Vectorio is a mixing and injection system for administering Guerbet's Lipiodol Ultra Fluid plus an anticancer drug during conventional transarterial chemoembolization (TACE) procedures in adults with intermediate-stage hepatocellular carcinoma. It received the CE Mark in August 2017, the company said.
